Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge ; volume:14 ; number:1 ; day:5 ; month:3 ; year:2024 ; pages:1-7 ; date:12.2024
Scientific reports ; 14, Heft 1 (5.3.2024), 1-7, 12.2024
- Urheber
-
Chesdachai, Supavit
Rivera, Christina G.
Cole, Kristin C.
Teaford, Hilary R.
Gonzalez Suarez, Maria L.
Larsen, Jennifer J.
Ganesh, Ravindra
Tulledge-Scheitel, Sidna
Razonable, Raymund R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-56195-y
- URN
-
urn:nbn:de:101:1-2405101103108.552315893243
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chesdachai, Supavit
- Rivera, Christina G.
- Cole, Kristin C.
- Teaford, Hilary R.
- Gonzalez Suarez, Maria L.
- Larsen, Jennifer J.
- Ganesh, Ravindra
- Tulledge-Scheitel, Sidna
- Razonable, Raymund R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study
Fatal cases after Omicron BA.1 and BA.2 infection: results of an autopsy study
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study
Fatal cases after Omicron BA.1 and BA.2 infection: results of an autopsy study
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study
Fatal cases after Omicron BA.1 and BA.2 infection: results of an autopsy study
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2